RA Capital Management »

Amanat Acquisition Corp shares owned by RA Capital Management

Quarter-by-quarter ownership of Amanat Acquisition Corp shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Amanat Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Amanat Acquisition Corp held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amanat Acquisition Corp by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.8M 375k 10.16

More positions owned by RA Capital Management

Ascendis Pharma A/s Common Stock (ASND)
Parabilis Medicines Common Stock
Rhythm Pharmaceuticals Common Stock (RYTM)
Vaxcyte Common Stock (PCVX)
Sionna Therapeutics Common Stock (SION)
Tyra Biosciences Common Stock (TYRA)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Hemab Therapeutics Holdings Common Stock
Septerna Common Stock (SEPN)
Bicara Therapeutics Common Stock (BCAX)
Mineralys Therapeutics Common Stock (MLYS)
Gh Research Common Stock (GHRS)
Disc Medicine Common Stock (IRON)
Spyglass Pharma Common Stock (SGP)

View all positions for RA Capital Management

Top funds holding Amanat Acquisition Corp

Nantahala Capital Management
ADAR1 Capital Management
OZ Management
Braidwell
Dr. Jeffrey R. Jay, M.D.
RA Capital Management
Affinity Asset Advisors
Toronto-Dominion Bank
Citadel Advisors
Millennium Management
Aristeia Capital
Ikarian Capital
Mizuho Securities Usa
Two Sigma Investments
Lineage Point Capital

View all funds holding Amanat Acquisition Corp